Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.42 |
| ▸ | MAPT | P10636 | 6/20 | 0.42 |
| ▸ | HPGD | P15428 | 6/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 5/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 4/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.42 |
| ▸ | BCHE | P06276 | 3/20 | 0.42 |
| ▸ | ACHE | P22303 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.42 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL543021 | 0.81 | BAD (0.56) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL29670768 | 0.81 | ALDH1A1 (0.54) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| SCHEMBL3677790 | 0.74 | RAC1 (0.54) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL8312714 | 0.73 | RAC1 (0.55) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| Fagaridine SCHEMBL29369428 | 0.72 | ALDH1A1 (0.77) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| Fagaridine SCHEMBL108986 | 0.72 | ALDH1A1 (0.77) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| Fagaridine SCHEMBL6961260 | 0.71 | ALDH1A1 (0.78) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| Fagaridine SCHEMBL9547964 | 0.71 | ALDH1A1 (0.76) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| Fagaridine SCHEMBL8711761 | 0.71 | ALDH1A1 (0.76) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 | |
| Fagaridine SCHEMBL31756471 | 0.69 | ALDH1A1 (0.65) | ALDH1A1MAPTHPGDMAPK1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2900241-A2 | NOVEL COMPOUNDS THAT ARE ERK INHIBITORS | Merck Sharp & Dohme Corp. (US) | 2015-08-05 | — | — | EP | disclosed |
| EP-2688872-A1 | AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES | Merck Sharp & Dohme Corp. (US) | 2014-01-29 | — | — | EP | disclosed |
| WO-2012129258-A1 | AMIDOPYRAZOLE INHIBITORS OF INTERLEUKIN RECEPTOR-ASSOCIATED KINASES | MERCK SHARP & DOHME CORP. (US) | 2012-09-27 | — | — | WO | disclosed |
| EP-2414330-A2 | PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS | Merck Patent GmbH (DE) | 2012-02-08 | — | — | EP | disclosed |
| EP-2310384-A1 | INHIBITORS OF JANUS KINASES | Merck Sharp & Dohme Corp. (US) | 2011-04-20 | — | — | EP | disclosed |
| WO-2010115491-A2 | PIPERIDINE AND PIPERAZINE DERIVATIVES AS AUTOTAXIN INHIBITORS | MERCK PATENT GMBH (DE) | 2010-10-14 | — | — | WO | disclosed |
| WO-2010005841-A1 | INHIBITORS OF JANUS KINASES | MERCK & CO., INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| EP-1656133-A4 | MITOTIC KINESIN INHIBITORS | MERCK & CO INC (US) | 2008-10-29 | — | — | EP | disclosed |
| EP-1874769-A1 | NOVEL AZA- HETEROCYCLES SERVING AS KINASE INHIBITORS | Merck Patent GmbH (DE) | 2008-01-09 | — | — | EP | disclosed |
| EP-1696927-A4 | MITOTIC KINESIN INHIBITORS | MERCK & CO INC (US) | 2007-10-31 | — | — | EP | disclosed |
| WO-2006023440-A2 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2006-03-02 | — | — | WO | disclosed |
| EP-1629284-A2 | METHODS FOR IDENTIFYING MODULATORS OF KINESIN ACTIVITY | Rosetta Inpharmatics LLC. (US) | 2006-03-01 | — | — | EP | disclosed |
| WO-2006017214-A2 | INHIBITORS OF HISTONE DEACETYLASE | MERCK & CO., INC. (US) | 2006-02-16 | — | — | WO | disclosed |
| WO-2005065183-A2 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2005-07-21 | — | — | WO | disclosed |
| EP-1534268-A2 | TYROSINE KINASE INHIBITORS | Merck & Co., Inc. (US) | 2005-06-01 | — | — | EP | disclosed |
| WO-2005019192-A1 | UREA DERIVATIVES AND THEIR USE AS TYROSINKINASE INHIBITORS | MERCK PATENT GMBH (DE) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005019216-A1 | AMINOBENZIMIDAZOLE DERIVATIVES | MERCK PATENT GMBH (DE) | 2005-03-03 | — | — | WO | disclosed |
| WO-2005017190-A2 | MITOTIC KINESIN INHIBITORS | MERCK & CO., INC. (US) | 2005-02-24 | — | — | WO | disclosed |
| WO-2004109290-A2 | METHODS FOR IDENTIFYING MODULATORS OF KINESIN ACTIVITY | ROSETTA INPHARMATICS LLC (US) | 2004-12-16 | — | — | WO | disclosed |
| WO-2004014300-A2 | TYROSINE KINASE INHIBITORS | MERCK & CO., INC. (US) | 2004-02-19 | — | — | WO | disclosed |